October was a rollercoaster month for the A2 Milk (ASX:A2M) share price

It was a very eventful month for A2 Milk shares in October…

| More on:
People on a rollercoaster waving hands in the air, indicating a plummeting or rising share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It certainly was an eventful month for the A2 Milk Company Ltd (ASX: A2M) share price in October.

The embattled infant formula company's shares ended the month one cent higher than where they started it at $6.25. However, that is only part of the story.

What happened to the A2 Milk share price in October?

The A2 Milk share price certainly was on a rollercoaster ride last month.

It was down as much as 7% month to date, then stormed higher to be up as much as 19% for the month, before ending the period broadly flat.

Investors were bidding the A2 Milk share price higher in the middle of October following the release of an update out of junior infant formula company Bubs Australia Ltd (ASX: BUB).

Like A2 Milk, Bubs has been struggling in recent quarters. This was due to disruption in the daigou channel, the increasing popularity of domestic infant formula brands in China, and subdued demand.

However, the company returned to form during the first quarter of FY 2022, reporting a strong increase in sales (albeit from a small base). The majority of Bubs' growth came from channels relating to the China market. This sparked hopes that the worst was now behind A2 Milk.

However, the A2 Milk share price quickly gave back those gains following the release of its investor update late on in the month.

What was the update?

A2 Milk's investor update laid out its expectations for the coming years. And as you may have guessed from the A2 Milk share price reaction, the next few years are not going to be as positive as many were hoping.

The company has set itself a medium term (≥ 5 years) target of growing its sales to NZ$2 billion. While this is a big increase on FY 2021's COVID-impacted sales of NZ$1.2 billion, it is only a modest increase on FY 2020's pre-COVID sales of NZ$1.73 billion.

In addition, management revealed that its EBITDA margins will "probably" be in the teens in the medium term due to expected market conditions, investments, and innovation. This is significantly weaker than FY 2020's EBITDA margin of 31.7%.

Management also warned that there was still some uncertainty with these growth targets. It said that "because of these uncertainties and the range of potential outcomes, it is very difficult to define future state targets and when they will be achieved – the path is also unlikely to be linear."

Where next for A2 Milk shares?

Opinion is largely divided on where the A2 Milk share price will go from here.

The bulls at Bell Potter have a buy rating and $7.70 price target on its shares, whereas the bears at Macquarie have an underperform rating and $5.20 price target. This compares to the current A2 Milk share price of $6.26.

Time will tell which broker makes the right call.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk and BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A picture of the US Federal Reserve podium for making media announcements.
Share Market News

Why the Fed just left interest rates on hold and what ASX investors can expect next

With the Fed keeping interest rates on hold, when can ASX investors expect the central bank’s next cut?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 114% in a year, why is the Pro Medicus share price leaping higher again on Thursday?

Pro Medicus shares are back in form today and leaping ahead. Here’s why.

Read more »

A railway worker walks along the train tracks in a visi vest and speaking into a walkie talkie.
Share Market News

Are Aurizon shares a buy, hold or sell based on Macquarie's report?

Here’s what this broker has to say about this Industrials stock

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Leading broker puts buy rating on Zip shares

Big returns could be on offer for investors according to its analysts.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Share Market News

5 things to watch on the ASX 200 on Thursday

A positive session is expected for Aussie investors today. Here's what is happening.

Read more »

Man standing on rock next to turquoise salt lagoon.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 finally had a green session this hump day.

Read more »

gaming asx share price rise represented by slot machine paying jackpot
Broker Notes

What does Macquarie expect from Aristocrat Leisure shares when it reports on 14 May?

Here's what the broker is expecting from this gaming technology company next week.

Read more »

Man pointing at a blue rising share price graph.
Share Gainers

Guess which ASX 300 stock just rocketed 17%!

Investors are sending the ASX 300 stock soaring higher on Wednesday. But why?

Read more »